Aethlon Medical (AEMD) Posts Earnings Results, Misses Expectations By $0.04 EPS

Aethlon Medical (NASDAQ:AEMD) posted its quarterly earnings results on Monday. The medical equipment provider reported ($0.11) EPS for the quarter, missing the Zacks’ consensus estimate of ($0.07) by ($0.04), Bloomberg Earnings reports.

NASDAQ:AEMD opened at $1.20 on Wednesday. Aethlon Medical has a 52 week low of $0.82 and a 52 week high of $2.04. The company has a market cap of $24.83 million, a PE ratio of -2.61 and a beta of 0.98.

A number of equities research analysts have recently commented on AEMD shares. HC Wainwright set a $3.00 price target on shares of Aethlon Medical and gave the company a “buy” rating in a report on Thursday, November 8th. ValuEngine upgraded shares of Aethlon Medical from a “sell” rating to a “hold” rating in a report on Wednesday, January 2nd.

ILLEGAL ACTIVITY WARNING: This article was first published by Markets Daily and is the sole property of of Markets Daily. If you are viewing this article on another domain, it was stolen and reposted in violation of United States & international copyright and trademark law. The original version of this article can be read at

About Aethlon Medical

Aethlon Medical, Inc, a medical device company, focuses on creating devices that address unmet medical needs in health and biodefense worldwide. The company is developing Aethlon Hemopurifier, a clinical-stage therapeutic device that eliminates life-threatening viruses from the circulatory system of infected individuals.

Read More: How to interpret a stock’s beta number

Earnings History for Aethlon Medical (NASDAQ:AEMD)

Receive News & Ratings for Aethlon Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aethlon Medical and related companies with's FREE daily email newsletter.

Leave a Reply